Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of Avigan for Severe Fever with Thrombocytopenia Syndrome
jRCT2061240089Recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of favipiravir in severe fever with thrombocytopenia syndrome (SFTS), sponsored by FUJIFILM Toyama Chemical. Primary endpoint: SFTSV genome load. Started Dec 2024; status: recruiting.
02
Drugs
favipiravir
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on jRCT2061240089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061240089.